BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 24920810)

  • 21. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
    Punjabi AS; Carroll PA; Chen L; Lagunoff M
    J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
    Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
    Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
    Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.
    Zeng Y; Zhang X; Huang Z; Cheng L; Yao S; Qin D; Chen X; Tang Q; Lv Z; Zhang L; Lu C
    J Virol; 2007 Mar; 81(5):2401-17. PubMed ID: 17151125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3β signaling pathway.
    Zhou F; Xue M; Qin D; Zhu X; Wang C; Zhu J; Hao T; Cheng L; Chen X; Bai Z; Feng N; Gao SJ; Lu C
    PLoS One; 2013; 8(1):e53145. PubMed ID: 23301033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response.
    Bussey KA; Reimer E; Todt H; Denker B; Gallo A; Konrad A; Ottinger M; Adler H; Stürzl M; Brune W; Brinkmann MM
    J Virol; 2014 Aug; 88(16):9245-59. PubMed ID: 24899179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells.
    Landis JT; Tuck R; Pan Y; Mosso CN; Eason AB; Moorad R; Marron JS; Dittmer DP
    mBio; 2022 Feb; 13(1):e0347321. PubMed ID: 35089062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation.
    Morris VA; Punjabi AS; Wells RC; Wittkopp CJ; Vart R; Lagunoff M
    Virology; 2012 Jul; 428(2):112-20. PubMed ID: 22521915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
    Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
    Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.
    Zhang YJ; Patel D; Nan Y; Fan S
    Antivir Ther; 2011; 16(5):657-66. PubMed ID: 21817187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oroxylin A inhibits Kaposi's sarcoma-associated herpes virus (KSHV) vIL-6-mediated lymphatic reprogramming of vascular endothelial cells through modulating PPARγ/Prox1 axis.
    Zhu X; Chen Y; Zhu W; Ji M; Xu J; Guo Y; Gao F; Gu W; Yang X; Zhang C
    J Med Virol; 2019 Mar; 91(3):463-472. PubMed ID: 30318784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease.
    Brousset P; Cesarman E; Meggetto F; Lamant L; Delsol G
    Hum Pathol; 2001 Jan; 32(1):95-100. PubMed ID: 11172301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral interleukin-6 encoded by an oncogenic virus promotes angiogenesis and cellular transformation by enhancing STAT3-mediated epigenetic silencing of caveolin 1.
    Li W; Wang Q; Qi X; Guo Y; Lu H; Chen Y; Lu Z; Yan Q; Zhu X; Jung JU; Tosato G; Gao SJ; Lu C
    Oncogene; 2020 Jun; 39(23):4603-4618. PubMed ID: 32393833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 promotes cell proliferation and migration by upregulating DNMT1 via STAT3 activation.
    Wu J; Xu Y; Mo D; Huang P; Sun R; Huang L; Pan S; Xu J
    PLoS One; 2014; 9(3):e93478. PubMed ID: 24675762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
    Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R
    PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression.
    Kang JG; Pripuzova N; Majerciak V; Kruhlak M; Le SY; Zheng ZM
    J Virol; 2011 Mar; 85(6):2620-30. PubMed ID: 21209110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival.
    Wang C; Zhu C; Wei F; Zhang L; Mo X; Feng Y; Xu J; Yuan Z; Robertson E; Cai Q
    J Virol; 2015 Oct; 89(20):10416-26. PubMed ID: 26246572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
    Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R
    Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization.
    Suthaus J; Adam N; Grötzinger J; Scheller J; Rose-John S
    Eur J Cell Biol; 2011; 90(6-7):495-504. PubMed ID: 21176991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promotion of Endoplasmic Reticulum-Associated Degradation of Procathepsin D by Human Herpesvirus 8-Encoded Viral Interleukin-6.
    Chen D; Nicholas J
    J Virol; 2015 Aug; 89(15):7979-90. PubMed ID: 26018151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.